Grant Opportunity for AFib and Stroke Prevention Research

The Heart Rhythm Society, in partnership with Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), is proud to announce a call for grant applications to support innovation and advancement in atrial fibrillation and stroke prevention research aimed at addressing National Quality Improvement (QI) priorities via demonstration projects/research. Through this effort, BIPI is providing $500,000 to support multiple grants to eligible applicants for proposals that aim to affect the behaviors and performance of patients, providers, and/or systems that when combined with existing standards and approaches to care, may enhance patient outcomes.  Click here for more information.